Cardiovascular Impact of Diabetes Meds
Medication Talk
Medication Talk
Cardiovascular Impact of Diabetes Meds
Apr 01, 2025 Season 4 Episode 2
TRC Healthcare

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.

Special Guests:

  • Lauren G. Pamulapati, PharmD, BCACP
    • Associate Professor, Ambulatory Care
    • Virginia Commonwealth University School of Pharmacy
    • Clinical Pharmacist, Hayes Willis Health Center/VCU Health
  • Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
    • Professor, Pharmacy Practice
    • Director, PGY2 Ambulatory Care Residency Program
    • Midwestern University College of Pharmacy, Downers Grove Campus
    • Clinical Pharmacist, Northwestern Medicine

TRC Editorial Advisory Board Participant:

  • Stephen Carek, MD, CAQSM, DipABLM
    • Clinical Associate Professor of Family Medicine
    • Prisma Health/USC-SOMG Family Medicine Residency Program
    • USC School of Medicine Greenville

For the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in February 2025.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights

Send us a text


If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Episode Artwork Cardiovascular Impact of Diabetes Meds 36:01 Episode Artwork Bronchitis and Pneumonia Treatment 35:14 Episode Artwork Notable New Meds of 2024 32:17 Episode Artwork Natural Medicines Highlights 55:46 Episode Artwork Immunization Updates 2024 36:16 Episode Artwork Cultural Competency in Healthcare 23:26 Episode Artwork Implicit Bias in Healthcare 28:59 Episode Artwork Asthma and COPD Treatment 35:13 Episode Artwork Precepting: Helping Learners Succeed 47:04 Episode Artwork Specialty Meds: Navigating Barriers 39:40 Episode Artwork Pharmacotherapy for Anxiety and Depression 31:22 Episode Artwork Opioids: Strategies for Safe Use 35:50 Episode Artwork Medication Safety Across Healthcare Teams 37:41 Episode Artwork Diabetes Treatment Updates 30:03 Episode Artwork Meds for Obesity and Weight Loss 33:18 Episode Artwork Rx and OTC Oral Contraceptives 34:25 Episode Artwork First-Line Meds for Hypertension 31:15 Episode Artwork Vaccine FAQs 33:34 Episode Artwork Managing Chronic Coronary Disease 33:34 Episode Artwork Flu Vaccine Updates 25:42 Episode Artwork RSV Vaccines in Older Adults 30:00 Episode Artwork Cardiovascular Risks with Testosterone 30:02 Episode Artwork Addressing Social Determinants of Health 23:54 Episode Artwork Debate About LDL Targets 31:34 Episode Artwork Sorting Through Penicillin Allergies 31:55